These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 17067190)

  • 1. Recent developments in decision-analytic modelling for economic evaluation.
    Weinstein MC
    Pharmacoeconomics; 2006; 24(11):1043-53. PubMed ID: 17067190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of modelling in prioritising and planning clinical trials.
    Chilcott J; Brennan A; Booth A; Karnon J; Tappenden P
    Health Technol Assess; 2003; 7(23):iii, 1-125. PubMed ID: 14499052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section.
    Cooper NJ; Sutton AJ; Abrams KR
    Stat Methods Med Res; 2002 Dec; 11(6):491-512. PubMed ID: 12516986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
    Hafner J
    J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Decision analytic modeling and their impact on health care decision making].
    Inotai A; Kaló Z; Mészáros A
    Acta Pharm Hung; 2009; 79(2):63-9. PubMed ID: 19634636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding and Identifying Key Issues with the Involvement of Clinicians in the Development of Decision-Analytic Model Structures: A Qualitative Study.
    Husbands S; Jowett S; Barton P; Coast J
    Pharmacoeconomics; 2018 Dec; 36(12):1453-1462. PubMed ID: 30117116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling in the economic evaluation of health care: selecting the appropriate approach.
    Barton P; Bryan S; Robinson S
    J Health Serv Res Policy; 2004 Apr; 9(2):110-8. PubMed ID: 15099459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacometrics: modelling and simulation tools to improve decision making in clinical drug development.
    Gieschke R; Steimer JL
    Eur J Drug Metab Pharmacokinet; 2000; 25(1):49-58. PubMed ID: 11032091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying dynamic simulation modeling methods in health care delivery research-the SIMULATE checklist: report of the ISPOR simulation modeling emerging good practices task force.
    Marshall DA; Burgos-Liz L; IJzerman MJ; Osgood ND; Padula WV; Higashi MK; Wong PK; Pasupathy KS; Crown W
    Value Health; 2015 Jan; 18(1):5-16. PubMed ID: 25595229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Qualitative Methods Can be Used to Inform Model Development.
    Husbands S; Jowett S; Barton P; Coast J
    Pharmacoeconomics; 2017 Jun; 35(6):607-612. PubMed ID: 28321640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the AHP methodology in system dynamics: Modelling and simulation for health technology assessments to determine the correct prosthesis choice for hernia diseases.
    Improta G; Russo MA; Triassi M; Converso G; Murino T; Santillo LC
    Math Biosci; 2018 May; 299():19-27. PubMed ID: 29518403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An introduction to the methods of decision-analytic modelling used in economic evaluations for Dermatologists.
    McManus E; Sach TH; Levell NJ
    J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1829-1836. PubMed ID: 31127965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decision analytic models for Alzheimer's disease: state of the art and future directions.
    Cohen JT; Neumann PJ
    Alzheimers Dement; 2008 May; 4(3):212-22. PubMed ID: 18631970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IMPACT: a generic tool for modelling and simulating public health policy.
    Ainsworth JD; Carruthers E; Couch P; Green N; O'Flaherty M; Sperrin M; Williams R; Asghar Z; Capewell S; Buchan IE
    Methods Inf Med; 2011; 50(5):454-63. PubMed ID: 21915434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mental health care system optimization from a health-economics perspective: where to sow and where to reap?
    Lokkerbol J; Weehuizen R; Mavranezouli I; Mihalopoulos C; Smit F
    J Ment Health Policy Econ; 2014 Jun; 17(2):51-60. PubMed ID: 25153093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Handling uncertainty in cost-effectiveness models.
    Briggs AH
    Pharmacoeconomics; 2000 May; 17(5):479-500. PubMed ID: 10977389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of Constrained Optimization Methods in Health Services Research: Report 2 of the ISPOR Optimization Methods Emerging Good Practices Task Force.
    Crown W; Buyukkaramikli N; Sir MY; Thokala P; Morton A; Marshall DA; Tosh JC; Ijzerman MJ; Padula WV; Pasupathy KS
    Value Health; 2018 Sep; 21(9):1019-1028. PubMed ID: 30224103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling during an emergency: the 2009 H1N1 influenza pandemic.
    Lee BY; Haidari LA; Lee MS
    Clin Microbiol Infect; 2013 Nov; 19(11):1014-22. PubMed ID: 23800220
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.